Over 1200 dead, curfews, quarantines and no way to actively treat the needy. When asked, an official from the WHO said they have no idea what kind of money it would require to solve the problem. SIGA has been mentioned multiple times, including the Forbes article yesterday. Smoke or Fire?
The mention from Forbes..as vague as one would expect:
"SIGA (NASDAQ:SIGA) is an anti-infective company headquartered in New York is working closely with federal agencies to develop a range of compounds that target diseases that could be used as bioweapons, such as smallpox. The company has one compound that it is developing to target filo-viruses such as Ebola.
SIGA uses analytical tools to evaluate the bacterial and viral genomes to find new targets against these bugs. The company is currently testing three different experimental drugs. SIGA’s compounds work by trying to prevent the Ebola virus from entering host cells. This would block the ability of the virus to replicate."